Exhibit 4.4

    

     

      

    PURSUANT TO THE TERMS OF SECTION 1 OF THIS WARRANT, ALL OR A PORTION OF THIS WARRANT MAY HAVE BEEN EXERCISED, AND THEREFORE THE ACTUAL NUMBER OF WARRANT SHARES REPRESENTED BY THIS WARRANT MAY BE LESS THAN THE
        AMOUNT SET FORTH ON THE FACE HEREOF.
      

      

      THIS PURCHASE WARRANT IS NOT EXERCISABLE PRIOR TO [•], 2021. VOID AFTER 5:00 P.M., EASTERN TIME, [•], 2026.

      

      

      VERDANT EARTH TECHNOLOGIES LIMITED

      

      

      Warrant To Purchase Ordinary Shares

      

      

      Warrant No.:

      Number of Ordinary Shares: [•]

      Date of Issuance: [•], 2021 (“Issuance Date”)

      

      

      Verdant Earth Technologies Limited, a company limited by shares incorporated and domiciled in Australia (the “Company”), hereby certifies that, for good and valuable
        consideration, the receipt and sufficiency of which are hereby acknowledged, [UNDERWRITER NAME], the registered holder hereof or its permitted assigns (the “Holder”), is entitled, subject to the terms set
        forth below, to purchase from the Company, at the Exercise Price (as defined below) then in effect, upon surrender of this Warrant to Purchase Ordinary Shares (including any Warrants to Purchase Ordinary Shares issued in exchange, transfer or
        replacement hereof, the “Warrant”), at any time or times on or after the Issuance Date (the “Exercisability Date”), but not after 11:59 p.m., New York time, on the
        Expiration Date (as defined below), [ ____________ (_____________)] fully paid nonassessable Ordinary Shares (the “Warrant Shares”). Except as otherwise defined herein, capitalized terms in this Warrant
        shall have the meanings set forth in Section 16. This Warrant is one of the Underwriter Warrants to Purchase Ordinary Shares (this “Warrant”) issued pursuant to (i) Section 4(f) of the Underwriting Agreement,
        dated as of [•], 2021 (the “Underwriting Agreement”), by and between the Company and Roth Capital Partners, LLC, as representative of the several underwriters listed therein (the “Underwriters”) and (ii) the Company’s Registration Statement on Form F-1 (File No.: 333-[●]) (the “Registration Statement”). This Warrant is one of a series of warrants containing
        substantially identical terms and conditions issued pursuant to Section 4(f) of the Underwriting Agreement (collectively, the “Warrants”).

      
        
          


      

      
      1.          EXERCISE OF WARRANT.

      

      

      (a)          Mechanics of Exercise. Subject to the terms and conditions hereof, this Warrant may be exercised by the Holder on any day on or after the Exercisability Date and prior to the Expiration Date (as
        defined below), in whole or in part (but not as to fractional shares), by delivery of a written notice, in the form attached hereto as Exhibit A (the “Exercise Notice”) of the Holder’s election to
        exercise this Warrant. No ink-original Exercise Notice shall be required, nor shall any medallion guarantee (or other type of guarantee or notarization) of any Exercise Notice form be required. Within two (2) Trading Days of the delivery of such
        Exercise Notice, if the Holder is not electing a Cashless Exercise (as defined below) pursuant to Section 1(d) of this Warrant, the Holder shall pay to the Company an amount equal to the applicable Exercise Price multiplied by the number of Warrant
        Shares as to which this Warrant is being exercised (the “Aggregate Exercise Price”) in cash or wire transfer of immediately available funds (a “Cash Exercise”). The
        Holder shall not be required to surrender this Warrant in order to effect an exercise hereunder; provided, however, that in the event that this Warrant is exercised in full or for the remaining unexercised portion hereof, the Holder shall deliver
        this Warrant to the Company for cancellation within a reasonable time after such exercise, but in any event within five (5) Trading Days of the delivery of the Exercise Notice. On or before the first (1st) Trading Day following the date on which
        the Company has received the Exercise Notice and the Aggregate Exercise Price, if any (the date upon which the Company has received the Exercise Notice and such Aggregate Exercise Price, the “Exercise Date”),
        the Company shall transmit by facsimile or e-mail transmission an acknowledgment of confirmation of receipt of the Exercise Notice to the Holder and the Company’s transfer agent for the Ordinary Shares (the “Transfer



          Agent”). The Company shall deliver in writing any objection to the Exercise Notice on or before the second (2nd) Trading Day following the date on which the Company has received the Exercise Notice. On or before the second (2nd) Trading
        Day following the date on which the Company has received the Exercise Notice and any Aggregate Exercise Price (the “Share Delivery Date”), the Company shall, (X) provided that the Transfer Agent is
        participating in The Depository Trust Company (“DTC”) Fast Automated Securities Transfer Program (the “FAST Program”) and so long as the certificates therefor are not
        required by this Warrant to bear a legend regarding restriction on transferability, upon the request of the Holder, credit such aggregate number of Ordinary Shares to which the Holder is entitled pursuant to such exercise to the Holder’s or its
        designee’s balance account with DTC through its Deposit Withdrawal Agent Commission system, or (Y), if the Transfer Agent is not participating in the FAST Program or if the certificates are required by this Warrant to bear a legend regarding
        restriction on transferability, issue and dispatch by overnight courier to the address specified in the Exercise Notice, a certificate, registered in the Company’s share register in the name of the Holder or its designee, for the number of Ordinary
        Shares to which the Holder is entitled pursuant to such exercise. Upon delivery of the Exercise Notice and payment of any Aggregate Exercise Price, the Holder shall be deemed for all corporate purposes to have become the holder of record of the
        Warrant Shares with respect to which this Warrant has been exercised (including for purposes of Section 6 hereof), irrespective of the date such Warrant Shares are credited to the Holder’s DTC account or the date of delivery of the certificates
        evidencing such Warrant Shares, as the case may be. If this Warrant is submitted in connection with any exercise pursuant to this Section 1(a) and the number of Warrant Shares represented by this Warrant submitted for exercise is greater than the
        number of Warrant Shares being acquired upon an exercise, then the Company shall as soon as practicable and in no event later than three (3) Trading Days after any such submission and at its own expense, issue a new Warrant (in accordance with
        Section 7(d) of this Warrant) representing the right to purchase the number of Warrant Shares purchasable immediately prior to such exercise under this Warrant, less the number of Warrant Shares with respect to which this Warrant has been and/or is
        exercised. The Company shall pay any and all taxes and other expenses of the Company (including overnight delivery charges) that may be payable with respect to the issuance and delivery of Warrant Shares upon exercise of this Warrant; provided,
        however, that the Company shall not be required to pay any tax which may be payable in respect of any Transfer (as defined below) involved in the registration of any certificates for Warrant Shares or Warrants in a name other than that of
        the Holder or an affiliate thereof. The Holder shall be responsible for all other tax liability that may arise as a result of holding or Transferring this Warrant or receiving Warrant Shares upon exercise hereof.

      
        2

        
          


      

      (b)          Exercise Price. For purposes of this Warrant, “Exercise Price” means $[•], subject to adjustment as provided herein.

      

      

      (c)          Company’s Failure to Timely Deliver Securities. If the Company shall fail for any reason or for no reason to issue to the Holder within five (5) Business Days of the Exercise Date a certificate
        for the number of Ordinary Shares to which the Holder is entitled and register such Ordinary Shares on the Company’s share register or to credit the Holder’s balance account with DTC for such number of Ordinary Shares to which the Holder is
        entitled upon the Holder’s exercise of this Warrant, and if on or after such Trading Day the Holder purchases, or another Person purchases on the Holder’s behalf or for the Holder’s account (in an open market transaction or otherwise), Ordinary
        Shares to deliver in satisfaction of a sale by the Holder of Ordinary Shares issuable upon such exercise that the Holder anticipated receiving from the Company (a “Buy-In”), then the Company shall, within
        three (3) Business Days after the Holder’s written request and in the Holder’s discretion, either (i) pay cash to the Holder in an amount equal to the Holder’s total purchase price (including brokerage commissions, if any) for the Ordinary Shares
        so purchased (the “Buy-In Price”), at which point the Company’s obligation to deliver such certificate (and to issue such Warrant Shares) shall terminate, or (ii) deliver to the Holder a certificate or
        certificates representing such Warrant Shares and pay cash to the Holder in an amount equal to the excess (if any) of the Buy-In Price over the product of (A) such number of Ordinary Shares, times (B) the Weighted Average Price (as reported by
        Bloomberg) on the date of the event giving rise to the Company’s obligation to deliver such Ordinary Shares. For the avoidance of doubt, the obligations of the Company pursuant to this Section 1(c) shall be in addition to any liability the Company
        may have to the Holder by law, in equity or otherwise, for failure to comply with the terms of this Warrant.

      

      

      (d)          Cashless Exercise. The Holder may, in its sole discretion, exercise this Warrant in whole or in part and, in lieu of making the cash payment otherwise contemplated to be made to the Company upon
        such exercise in payment of the Aggregate Exercise Price, elect instead to receive upon such exercise the “Net Number” of Ordinary Shares determined according to the following formula (a “Cashless Exercise”):

      

      

      X          = (Y) (A - B)

                           (A)

      

      

      For purposes of the foregoing formula:

      

      

      X = The number of Shares to be issued to Holder.

      

      

      A = the Weighted Average Price for the three (3) consecutive Trading Days ending on the date immediately preceding the date of the Exercise Notice.

      

      

      B = the Exercise Price then in effect for the applicable Warrant Shares at the time of such exercise.

      
        3

        
          


      

      Y = The number of Shares that would be issuable upon exercise of this Warrant in accordance with the terms of this Warrant if such exercise were by means of a cash exercise rather than a cashless exercise.

      

      

      (e)          Rule 144. For purposes of Rule 144(d) promulgated under the Securities Act of 1933, as amended, as in effect on the date hereof, assuming the Holder is not an affiliate of the Company, it is
        intended that the Warrant Shares issued in a Cashless Exercise shall be deemed to have been acquired by the Holder, and the holding period for the Warrant Shares shall be deemed to have commenced, on the Issuance Date.

      

      

      (f)          Disputes. In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the Warrant Shares, the Company shall promptly issue to the Holder the number of
        Warrant Shares that are not disputed.

      

      

      (g)          Beneficial Ownership. The Company shall not effect the exercise of this Warrant, and the Holder shall not have the right to exercise this Warrant, to the extent that after giving effect to such
        exercise, the Holder (together with the Holder’s affiliates) would beneficially own in excess of 4.99% (the “Maximum Percentage”) of the Ordinary Shares outstanding immediately after giving effect to such
        exercise. For purposes of the foregoing sentence, the aggregate number of Ordinary Shares beneficially owned by the Holder and its affiliates shall include the number of Ordinary Shares issuable upon exercise of this Warrant with respect to which
        the determination of such sentence is being made, but shall exclude Ordinary Shares which would be issuable upon (i) exercise of the remaining, unexercised portion of this Warrant beneficially owned by the Holder and its affiliates and (ii)
        exercise or conversion of the unexercised or unconverted portion of any other securities of the Company beneficially owned by the Holder and its affiliates (including, without limitation, any convertible notes or convertible preferred stock or
        warrants) subject to a limitation on conversion or exercise analogous to the limitation contained herein. Except as set forth in the preceding sentence, for purposes of this paragraph, beneficial ownership shall be calculated in accordance with
        Section 13(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). For purposes of this Warrant, in determining the number of outstanding Ordinary Shares, the Holder may rely on the number
        of outstanding Ordinary Shares as reflected in the most recent of (1) the Company’s most recent Form 20-F, Current Report on Form 6-K or other public filing with the Securities and Exchange Commission, as the case may be, (2) a more recent public
        announcement by the Company or (3) any other notice by the Company or the Transfer Agent setting forth the number of Ordinary Shares outstanding. Upon the reasonable request of the Holder, where such request indicates that it is being made pursuant
        to this Warrant, the Company shall within two (2) Business Days confirm to the Holder the number of Ordinary Shares then outstanding. In any case, the number of outstanding Ordinary Shares shall be determined after giving effect to the conversion
        or exercise of securities of the Company, including this Warrant, by the Holder and its affiliates since the date as of which such number of outstanding Ordinary Shares was reported. By written notice to the Company, the Holder may from time to
        time increase or decrease the Maximum Percentage to any other percentage not in excess of 9.99% specified in such notice; provided that (i) any such increase will not be effective until the sixty-first (61st) day after such notice is delivered to
        the Company, and (ii) any such increase or decrease will apply only to the Holder. The provisions of this paragraph shall not be construed and implemented in a manner otherwise than in strict conformity with the terms of this Section 1(g) to
        correct this paragraph (or any portion hereof) which may be defective or inconsistent with the intended beneficial ownership limitation herein contained or to make changes or supplements necessary or desirable to properly give effect to such
        limitation. The Holder shall be responsible, at the Holder’s cost, for any filings with the Securities and Exchange Commission required to be made by the Holder on account of its ownership of this Warrant or the underlying Warrant Shares.

      
        4

        
          


      

      (h)          Warrant Redemption. The Company may not call or redeem any portion of this Warrant without the prior written consent of the affected Holder.

      

      

      2.          ADJUSTMENT OF EXERCISE PRICE AND NUMBER OF WARRANT SHARES. The Exercise Price and the number of Warrant Shares shall be adjusted from time to time as follows:

      

      

      (a)          Voluntary Adjustment by Company. The Company may at any time during the term of this Warrant reduce the then current Exercise Price to any amount and for any period of time deemed appropriate by
        the Board of Directors of the Company.

      

      

      (b)          Adjustment upon Subdivision or Combination of Ordinary Shares. If the Company at any time on or after the Issuance Date subdivides (by any stock split, stock dividend, recapitalization,
        reorganization, scheme, arrangement or otherwise) one or more classes of its outstanding Ordinary Shares into a greater number of shares, the Exercise Price in effect immediately prior to such subdivision will be proportionately reduced and the
        number of Warrant Shares will be proportionately increased. If the Company at any time on or after the Issuance Date combines (by any stock split, stock dividend, recapitalization, reorganization, scheme, arrangement or otherwise) one or more
        classes of its outstanding Ordinary Shares into a smaller number of shares, the Exercise Price in effect immediately prior to such combination will be proportionately increased and the number of Warrant Shares will be proportionately decreased. Any
        adjustment under this Section 2(b) shall become effective at the close of business on the date the subdivision or combination becomes effective.

      

      

      (c)          Other Events. If any event occurs of the type contemplated by the provisions of this Section 2 but not expressly provided for by such provisions (including, without limitation, the granting of
        stock appreciation rights or phantom stock rights), then the Company’s Board of Directors will make an appropriate adjustment in the Exercise Price and the number of Warrant Shares so as to protect the rights of the Holder; provided that no such
        adjustment pursuant to this Section 2(c) will increase the Exercise Price or decrease the number of Warrant Shares as otherwise determined pursuant to this Section 2.

      

      

      (d)          Elimination of Fractional Interests. The Company shall not be required to issue certificates representing fractions of Ordinary
          Shares upon the exercise of the Warrant. As to any fraction of an Ordinary Share which the Holder would otherwise be entitled to purchase upon such exercise, the Company shall, at its election, either pay a cash adjustment in respect of such
          final fraction in an amount equal to such fraction multiplied by the Weighted Average Price of an Ordinary Share as of the date of exercise pursuant to Section 1(a) or 1(d), as applicable, or round up to the next whole Ordinary Share.

      
        5

        
          


      

      3.          RIGHTS UPON DISTRIBUTION OF ASSETS.

      

      

      (a)          If the Company, at any time while this Warrant is outstanding, shall distribute to all holders of Ordinary Shares (and not to the Holders) evidences of its indebtedness or assets (including cash and
        cash dividends) or rights or warrants to subscribe for or purchase any security (including, without limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin off, reclassification, corporate
        rearrangement, scheme of arrangement or other similar transaction), then in each such case the Exercise Price shall be adjusted by multiplying the Exercise Price in effect immediately prior to the record date fixed for determination of stockholders
        entitled to receive such distribution by a fraction of which the denominator shall be the Weighted Average Price determined as of the record date mentioned above, and of which the numerator shall be such Weighted Average Price on such record date
        less the then per share fair market value at such record date of the portion of such assets or evidence of indebtedness so distributed applicable to one outstanding Ordinary Shares as determined by the Board of Directors in good faith. In either
        case, the adjustments shall be described in a statement provided to the Holder of the portion of assets or evidences of indebtedness so distributed or such subscription rights applicable to one Ordinary Share. Such adjustment shall be made whenever
        any such distribution is made to the holders of Ordinary Shares and shall become effective immediately after the record date mentioned above.

      

      

      4.          PURCHASE RIGHTS; FUNDAMENTAL TRANSACTIONS.

      

      

      (a)          Purchase Rights. In addition to any adjustments pursuant to Section 2 above, if at any time prior to the Expiration Date the Company grants, issues or sells any Options, Convertible Securities or
        rights to purchase stock, warrants, securities or other property pro rata to the record holders of any class of Ordinary Shares (the “Purchase Rights”), then the Holder will be entitled to acquire, upon the
        terms applicable to such Purchase Rights, the aggregate Purchase Rights which the Holder could have acquired if the Holder had held the number of Ordinary Shares acquirable upon complete exercise of this Warrant (without regard to any limitations
        on the exercise of this Warrant) immediately before the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date as of which the record holders of Ordinary Shares are to be
        determined for the grant, issue or sale of such Purchase Rights.

      

      

      (b)          Fundamental Transactions. The Company shall not enter into or be party to a Fundamental Transaction unless the Successor Entity assumes in writing (unless the Company is the Successor Entity) all
        of the obligations of the Company under this Warrant in accordance with the provisions of this Section 4(b) pursuant to written agreements in form and substance reasonably satisfactory to the Required Holders and approved by the Required Holders
        prior to such Fundamental Transaction, including agreements to deliver to each Holder of the Warrants in exchange for such Warrants a security of the Successor Entity evidenced by a written instrument substantially similar in form and substance to
        this Warrant, including, without limitation, an adjusted exercise price equal to the value for the Ordinary Shares reflected by the terms of such Fundamental Transaction, and exercisable for a corresponding number of shares of capital stock
        equivalent to the Ordinary Shares acquirable and receivable upon exercise of this Warrant (without regard to any limitations on the exercise of this Warrant) prior to such Fundamental Transaction, and reasonably satisfactory to the Required
        Holders. Upon the occurrence of any Fundamental Transaction, unless the Company is the Successor Entity, the Successor Entity shall succeed to, and be substituted for (so that from and after the date of such Fundamental Transaction, the provisions
        of this Warrant referring to the “Company” shall refer instead to the Successor Entity), and may exercise every right and power of the Company and shall assume all of the obligations of the Company under this
        Warrant with the same effect as if such Successor Entity had been named as the Company herein. Upon consummation of the Fundamental Transaction, the Successor Entity shall deliver to the Holder confirmation that there shall be issued upon exercise
        of this Warrant at any time after the consummation of the Fundamental Transaction, in lieu of the Ordinary Shares (or other securities, cash, assets or other property) issuable upon the exercise of the Warrant prior to such Fundamental Transaction,
        such Ordinary Shares (or its equivalent) of the Successor Entity (including its Parent Entity) which the Holder would have been entitled to receive upon the happening of such Fundamental Transaction had this Warrant been converted immediately prior
        to such Fundamental Transaction, as adjusted in accordance with the provisions of this Warrant. In addition to and not in substitution for any other rights hereunder, prior to the consummation of any Fundamental Transaction pursuant to which
        holders of Ordinary Shares are entitled to receive securities or other assets with respect to or in exchange for Ordinary Shares (a “Corporate Event”), the Company shall make appropriate provision to ensure
        that the Holder will thereafter have the right to receive upon an exercise of this Warrant at any time after the consummation of the Corporate Event but prior to the Expiration Date, in lieu of Ordinary Shares (or other securities, cash, assets or
        other property) purchasable upon the exercise of this Warrant prior to such Corporate Event, such shares of stock, securities, cash, assets or any other property whatsoever (including warrants or other purchase or subscription rights) which the
        Holder would have been entitled to receive upon the happening of such Corporate Event had this Warrant been exercised immediately prior to such Corporate Event. Any provision made pursuant to the preceding sentence shall be in a form and substance
        reasonably satisfactory to the Required Holders.

      
        6

        
          


      

      (c)          Applicability to Successive Transactions. The provisions of this Section 4 shall apply similarly and equally to successive Fundamental Transactions and Corporate Events and shall be applied
        without regard to any limitations on the exercise of this Warrant.

      

      

      5.          NONCIRCUMVENTION. The Company hereby covenants and agrees that the Company will not, by amendment of its Constitution or like organizational document or through any reorganization, transfer of
        assets, consolidation, merger, scheme of arrangement, dissolution, issue or sale of securities, or any other voluntary action, take any action designed or intended to avoid the observance or performance of any of the terms of this Warrant, and will
        at all times in good faith comply with all the provisions of this Warrant and take all actions consistent with effectuating the purposes of this Warrant. Without limiting the generality of the foregoing, the Company covenants and agrees that it
        shall take all such actions as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable Ordinary Shares, not subject to preemptive rights of any shareholder, upon the exercise of this
        Warrant, including reserving from its Ordinary Shares such number of Ordinary Shares as are from time to time issuable pursuant to this Warrant. As long as this Warrant shall be outstanding, the Company shall use its
          best efforts to cause all Ordinary Shares issuable upon exercise of this Warrant to be listed (subject to official notice of issuance) on the Principal Market on which the Ordinary Shares issued to the public in the offering may then be listed.

      

      

      6.          WARRANT HOLDER NOT DEEMED A STOCKHOLDER. Except as otherwise specifically provided herein, the Holder, solely in such Person’s capacity as a holder of this Warrant, shall not be entitled to vote or
        receive dividends or be deemed the holder of share capital of the Company for any purpose, nor shall anything contained in this Warrant be construed to confer upon the Holder, solely in such Person’s capacity as the Holder of this Warrant, any of
        the rights of a stockholder of the Company or any right to vote, give or withhold consent to any corporate action (whether any reorganization, issue of stock, reclassification of stock, consolidation, merger, conveyance or otherwise), receive
        notice of meetings, receive dividends or subscription rights, or otherwise, prior to the issuance to the Holder of the Warrant Shares which such Person is then entitled to receive upon the due exercise of this Warrant. In addition, nothing
        contained in this Warrant shall be construed as imposing any liabilities on the Holder to purchase any securities (upon exercise of this Warrant or otherwise) or as a stockholder of the Company, whether such liabilities are asserted by the Company
        or by creditors of the Company.

      
        7

        
          


      

      7.          REISSUANCE OF WARRANTS.

      

      

      (a)          Transfer of Warrant. For a period of one hundred and eighty (180) days following the date of commencement of sales of the offering (the “Commencement Date”),


        this Warrant and the Warrant Shares shall not be (i) sold, transferred, assigned, pledged, hypothecated or otherwise transferred (“Transferred”) or (ii) be the subject of any hedging, short sale, derivative,
        put, or call transaction that would result in the effective economic disposition of the securities, except (1) in compliance with the Securities Act and applicable state securities laws and (2) in compliance with Section 15 hereof. If this Warrant
        is to be Transferred, the Holder shall surrender this Warrant to the Company and deliver the completed and executed Assignment Form, in the form attached hereto as Exhibit B, whereupon the Company will forthwith issue and deliver upon the
        order of the Holder a new Warrant (in accordance with Section 7(d)), registered as the Holder may request, representing the right to purchase the number of Warrant Shares being Transferred by the Holder and, if less than the total number of Warrant
        Shares then underlying this Warrant is being Transferred, a new Warrant (in accordance with Section 7(d)) to the Holder representing the right to purchase the number of Warrant Shares not being Transferred.

      

      

      (b)          Lost, Stolen or Mutilated Warrant. Upon receipt by the Company of evidence reasonably satisfactory to the Company of the loss, theft, destruction or mutilation of this Warrant, and, in the case
        of loss, theft or destruction, of any indemnification undertaking by the Holder to the Company in reasonable and customary form and, in the case of mutilation, upon surrender and cancellation of this Warrant, the Company shall execute and deliver
        to the Holder a new Warrant (in accordance with Section 7(d)) representing the right to purchase the Warrant Shares then underlying this Warrant.

      

      

      (c)          Exchangeable for Multiple Warrants. This Warrant is exchangeable, upon the surrender hereof by the Holder at the principal office of the Company, for a new Warrant or Warrants (in accordance with
        Section 7(d)) representing in the aggregate the right to purchase the number of Warrant Shares then underlying this Warrant, and each such new Warrant will represent the right to purchase such portion of such Warrant Shares as is designated by the
        Holder at the time of such surrender; provided, however, that no Warrants for fractional Ordinary Shares shall be given.

      
        8

        
          


      

      (d)          Issuance of New Warrants. Whenever the Company is required to issue a new Warrant pursuant to the terms of this Warrant, such new Warrant (i) shall be of like tenor with this Warrant, (ii) shall
        represent, as indicated on the face of such new Warrant, the right to purchase the Warrant Shares then underlying this Warrant (or in the case of a new Warrant being issued pursuant to Section 7(a) or Section 7(c), the Warrant Shares designated by
        the Holder which, when added to the number of Ordinary Shares underlying the other new Warrants issued in connection with such issuance, do not exceed the number of Warrant Shares then underlying this Warrant), (iii) shall have an issuance date, as
        indicated on the face of such new Warrant which is the same as the Issuance Date, and (iv) shall have the same rights and conditions as this Warrant.

      

      

      8.          NOTICES.

      

      

      (a)          Holder’s Right to Receive Notice. Nothing herein shall be construed as conferring upon the Holder the right to vote or consent
          or to receive notice as a shareholder for the election of directors or any other matter, or as having any rights whatsoever as a shareholder of the Company. If, however, at any time prior to the Expiration Date and the exercise of this Warrant in
          full, any of the events described in Section 8(b) shall occur, then, in one or more of said events, the Company shall give written notice of such event at least fifteen (15) Business Days prior to the date fixed as a record date or the date of
          closing the transfer books (the “Notice Date”) for the determination of the shareholders entitled to such dividend, distribution, conversion or exchange
          of securities or subscription rights, or entitled to vote on such proposed dissolution, liquidation, winding up or sale. Such notice shall specify such record date or the date of the closing of the transfer books, as the case may be.
          Notwithstanding the foregoing, the Company shall deliver to each Holder a copy of each notice given to the other shareholders of the Company at the same time and in the same manner that such notice is given to the shareholders.

      

      

      (b)          Events Requiring Notice. The Company shall be required to give the notice described in this Section 8 upon one or more of the
          following events: (i) if the Company shall take a record of the holders of its shares for the purpose of entitling them to receive a dividend or distribution payable otherwise than in cash, or a cash dividend or distribution payable otherwise
          than out of retained earnings, as indicated by the accounting treatment of such dividend or distribution on the books of the Company, (ii) the Company shall offer to all the holders of its shares any additional shares of capital stock of the
          Company or securities convertible into or exchangeable for shares of capital stock of the Company, or any option, right or warrant to subscribe therefor, or (iii) a dissolution, liquidation or winding up of the Company (other than in connection
          with a consolidation or share reconstruction or amalgamation) or a sale of all or substantially all of its property, assets and business shall be proposed.

      

      

      (c)          Notice of Change in Exercise Price. The Company shall, promptly after an event requiring a change in the Exercise Price pursuant
          to Sections 2, 3 or 4 hereof, send notice to the Holder of such event and change (“Price Notice”). The Price Notice shall describe the event causing the
          change and the method of calculating same and shall be certified as being true and accurate by the Company’s Chief Financial Officer.

      
        9

        
          


      

      (d)          Transmittal of Notices. The Company shall provide Holder with prompt written notice of all actions taken pursuant to this Warrant. Whenever notice is required to be given under this Warrant,
        unless otherwise provided herein, such notice shall be given in writing, will be delivered by International Federal Express, or any other nationally recognized overnight express courier, by facsimile or e-mail, and will be deemed delivered by
        International Federal Express or any other nationally recognized overnight carrier, two (2) Business Days after so mailed and, if delivered by facsimile or e-mail, upon electronic confirmation of receipt, and will be delivered and addressed as
        follows:

       

      

      	 	
              (i)

            	
              if to the Company, to:

            
	 	 	 
	 	 	
              Verdant Earth Technologies Limited

            
	 	 	
              Level 33, Colonial Centre

            
	 	 	
              52 Martin Place

              Sydney NSW 2000

              Australia

            
	 	 	
              Attn: Warren Kember

            
	 	 	
              

              

            
	 	 	with a copy to:
	 	 	 
	 	 	
              Gibson, Dunn & Crutcher LLP

            
	 	 	
              200 Park Avenue

            
	 	 	
              New York, New York 10166

            
	 	 	
              Attn: John T. Gaffney, Esq.

            
	 	 	
              Tel: (212) 351- 2626

            
	 	 	
              Fax: (212) 351-4035

            
	 	 	
              E-Mail: JGaffney@gibsondunn.com

            
	 	 	 
	 	(ii)

            	if to the Holder, at the address of the Holder appearing on the books of the Company.
	 	 	 
	 	 	with a copy to:
	 	 	 
	 	 	Pillsbury Winthrop Shaw Pittman LLP
	 	 	31 West 52nd Street
	 	 	New York, New York 10019
	 	 	Attn: Jonathan J. Russo, Esq.
	 	 	Tel: (212) 858-1000
	 	 	Fax: (212) 858-1500


      

      9.          AMENDMENT AND WAIVER. Except as otherwise provided herein, the provisions of this Warrant may be amended and the Company may take any action herein prohibited, or omit to perform any act herein
        required to be performed by it, only if the Company has obtained the prior written consent of the Required Holders. Any such amendment shall apply to all Warrants and be binding upon all registered holders of such Warrants.

      
        10

        
          


      

      10.          GOVERNING LAW; CONSENT TO JURISDICTION; WAIVER OF JURY TRIAL. This Warrant shall be governed by, and construed in accordance with, the internal laws of the State of New York, without reference to
        the choice of law provisions thereof. The Company and, by accepting this Warrant, the Holder, each irrevocably submits to the exclusive jurisdiction of the courts of the State of New York located in New York County and the United States District
        Court for the Southern District of New York for the purpose of any suit, action, proceeding or judgment relating to or arising out of this Warrant and the transactions contemplated hereby (each, a “Proceeding”).



        Service of process in connection with any such Proceeding may be served on each party hereto anywhere in the world by the same methods as are specified for the giving of notices under this Warrant. The Company and, by accepting this Warrant, the
        Holder, each irrevocably consents to the jurisdiction of any such court in any such Proceeding and to the laying of venue in such court. The Company and, by accepting this Warrant, the Holder, each irrevocably waives any objection to the laying of
        venue of any such Proceeding brought in such courts and irrevocably waives any claim that any such Proceeding brought in any such court has been brought in an inconvenient forum. The Company hereby irrevocably appoints CT Corporation System, with
        offices at 35 Liberty Street, New York, New York 10005, as agent for service of process in any Proceeding and agrees that service of process in any manner permitted by applicable laws in any such Proceeding may be made upon the Company at the
        office of such agent. The Company represents and warrants that such agent has agreed to act as agent for service of process, and agrees to take any and all action, including the filing of any and all documents and instruments, that may be necessary
        to continue such appointment in full force and effect. EACH OF THE COMPANY AND, BY ITS ACCEPTANCE HEREOF, THE HOLDER, HEREBY WAIVES ANY RIGHT TO REQUEST A TRIAL BY JURY IN ANY PROCEEDING WITH RESPECT TO THIS
          WARRANTS AND REPRESENTS THAT COUNSEL HAS BEEN CONSULTED SPECIFICALLY AS TO THIS WAIVER.

      

      

      11.          JUDGMENT CURRENCY. If for the purposes of obtaining judgment in any court it is necessary to convert a sum due hereunder into any currency other than United States dollars, the parties hereto
        agree, to the fullest extent permitted by law, that the rate of exchange used shall be the rate at which in accordance with normal banking procedures the Holder could purchase United States dollars with such other currency in The City of New York
        on the Business Day preceding that on which final judgment is given. The obligation of the Company with respect to any sum due to the Holder or any person affiliated with or controlling the Holder shall, notwithstanding any judgment in a currency
        other than United States dollars, not be discharged until the first Business Day following receipt by the Holder or such affiliated or controlling person of any sum in such other currency, and only to the extent that the Holder or such affiliated
        or controlling person may in accordance with normal banking procedures purchase United States dollars with such other currency. If the United States dollars so purchased are less than the sum originally due to the Holder or such affiliated or
        controlling person hereunder, the Company agrees as a separate obligation and notwithstanding any such judgment, to indemnify such Holder or such affiliated or controlling person against such loss. If the United States dollars so purchased are
        greater than the sum originally due to such Holder or such affiliated or controlling person hereunder, such Holder or such affiliated or controlling person agrees to pay to the Company an amount equal to the excess of the dollars so purchased over
        the sum originally due to the Holder or such affiliated or controlling person hereunder.

      

      

      12.          CONSTRUCTION; HEADINGS. This Warrant shall be deemed to be jointly drafted by the Company and the Holder and shall not be construed against any person as the drafter hereof. The headings of this
        Warrant are for convenience of reference and shall not form part of, or affect the interpretation of, this Warrant.

      
        11

        
          


      

      13.          DISPUTE RESOLUTION. In the case of a dispute as to the determination of the Exercise Price or the arithmetic calculation of the Warrant Shares, the Company shall submit the disputed
        determinations or arithmetic calculations via facsimile or e-mail within two (2) Business Days of receipt of the Exercise Notice giving rise to such dispute, as the case may be, to the Holder. If the Holder and the Company are unable to agree upon
        such determination or calculation of the Exercise Price or the Warrant Shares within three (3) Business Days of such disputed determination or arithmetic calculation being submitted to the Holder, then the Company shall, within two (2) Business
        Days submit via facsimile or e-mail (a) the disputed determination of the Exercise Price to an independent, nationally recognized investment bank selected by the Company in good faith by its Board of Directors and approved by the Holder, which
        approval shall not be unreasonably withheld, or (b) the disputed arithmetic calculation of the Warrant Shares to an independent, nationally recognized outside accountant selected by the Company good faith by its Board of Directors and approved by
        the Holder, which approval shall not be unreasonably withheld. The Company shall cause the investment bank or the accountant, as the case may be, to perform the determinations or calculations and notify the Company and the Holder of the results no
        later than ten (10) Business Days from the time it receives the disputed determinations or calculations. The prevailing party (which, for purposes of this Warrant, is the party whose determinations or calculations is closest to those of the
        investment bank or the accountant, as the case may be) in any dispute resolved pursuant to this Section 13 shall be entitled to the full amount of all reasonable expenses, including all costs and fees paid or incurred in good faith, in relation to
        the resolution of such dispute. Such investment bank’s or accountant’s determination or calculation, as the case may be, shall be binding upon all parties absent demonstrable error.

      

      

      14.          REMEDIES, OTHER OBLIGATIONS, BREACHES AND INJUNCTIVE RELIEF. The remedies provided in this Warrant shall be cumulative and in addition to all other remedies available under this Warrant, at law
        or in equity (including a decree of specific performance and/or other injunctive relief). The Company’s obligations to issue and deliver Warrant Shares in accordance with the terms hereof are absolute and unconditional, irrespective of any action
        or inaction by the Holder to enforce the same, any waiver or consent with respect to any provision hereof, the recovery of any judgment against any Person or any action to enforce the same, or any setoff, counterclaim, recoupment, limitation or
        termination, or any breach or alleged breach by the Holder or any other Person of any obligation to the Company or any violation or alleged violation of law by the Holder or any other Person, and irrespective of any other circumstance which might
        otherwise limit such obligation of the Company to the Holder in connection with the issuance of Warrant Shares.  Nothing herein shall limit the right of the Holder to pursue actual damages for any failure by the Company to comply with the terms of
        this Warrant.

      

      

      15.          TRANSFER. Subject to applicable laws and the restrictions set forth in this Section 15, this Warrant may be Transferred without the consent of the Company.

      

      

      (a)          The Holder of this Warrant agrees that such Holder will not for a period of one hundred and eighty (180) days following the Commencement Date: (i) Transfer this Warrant or the securities issuable
        hereunder to anyone other than: (x) an Underwriter or a selected dealer participating in the offering contemplated by the Underwriting Agreement, or (y) bona fide officers or partners of any such Underwriter or selected dealer, each of whom shall
        have agreed to the restrictions contained herein, in accordance with FINRA Rule 5110(e)(1), and (ii) cause this Warrant or the securities issuable hereunder to be the subject of any hedging, short sale, derivative, put or call transaction that
        would result in the effective economic disposition of this Warrant or the securities hereunder, except as provided for in FINRA Rule 5110(e)(2). On and after the Commencement Date, and subject to the preceding sentence, transfers to others may be
        made subject to compliance with or exemptions from applicable securities laws. In order to make any permitted assignment, the Holder must deliver to the Company the Assignment Form attached hereto as Exhibit B duly executed and completed,
        together with this Warrant and payment of all transfer taxes, if any, payable in connection therewith. The Company shall within three (3) Business Days transfer this Warrant on the books of the Company and shall execute and deliver a new Warrant or
        Warrants of like tenor to the appropriate assignee(s) expressly evidencing the right to purchase the aggregate number of Shares purchasable hereunder or such portion of such number as shall be contemplated by any such assignment in accordance with
        Section 7 hereunder. In addition, notwithstanding the other terms of this Warrant or any agreement between the Company and the Holder, the Holder agrees that, consistent with FINRA Rule 5110(g)(8): (i) this Warrant may not be exercised more than
        five (5) years from the Commencement Date; (ii) this Warrant may not have anti-dilution terms that allow the Holder and related persons to receive more shares or to exercise at a lower price than originally agreed upon at the time of the public
        offering, when the public shareholders have not been proportionally affected by a stock split, stock dividend, or other similar event; and (iii) this Warrant may not have anti-dilution terms that allow the Holder and related persons to receive or
        accrue cash dividends prior to the exercise or conversion of this Warrant.

      
        12

        
          


      

      (b)          The Holder agrees that in connection with any Transfer of the Warrant or the Warrant Shares it will deliver customary representation letters and legal opinions reasonably satisfactory to the Company, as
        reasonably requested by the Company.

      

      

      16.          CERTAIN DEFINITIONS. For purposes of this Warrant, the following terms shall have the following meanings:

      

      

      (a)          “Bloomberg” means Bloomberg Financial Markets.

      

      

      (b)          “Business Day” means any day other than Saturday, Sunday or other day on which commercial banks in the City of New York are authorized or required by law to
        remain closed.

      

      

      (c)          “Closing Bid Price” and “Closing Sale Price” means, for any security as of any date, the last closing bid price and last
        closing trade price, respectively, for such security on the Principal Market, as reported by Bloomberg, or, if the Principal Market begins to operate on an extended hours basis and does not designate the closing bid price or the closing trade
        price, as the case may be, then the last bid price or the last trade price, respectively, of such security prior to 4:00:00 p.m., New York time, as reported by Bloomberg, or, if the Principal Market is not the principal securities exchange or
        trading market for such security, the last closing bid price or last trade price, respectively, of such security on the principal securities exchange or trading market where such security is listed or traded as reported by Bloomberg, or if the
        foregoing do not apply, the last closing bid price or last trade price, respectively, of such security in the over-the-counter market on the electronic bulletin board for such security as reported by Bloomberg, or, if no closing bid price or last
        trade price, respectively, is reported for such security by Bloomberg, the average of the bid prices, or the ask prices, respectively, of any market makers for such security as reported in the “pink sheets” by Pink Sheets LLC (formerly the National
        Quotation Bureau, Inc.). If the Closing Bid Price or the Closing Sale Price cannot be calculated for a security on a particular date on any of the foregoing bases, the Closing Bid Price or the Closing Sale Price, as the case may be, of such
        security on such date shall be the fair market value as mutually determined by the Company and the Holder. All such determinations to be appropriately adjusted for any stock dividend, stock split, stock combination or other similar transaction
        during the applicable calculation period.

      
        13

        
          


      

      (d)          “Convertible Securities” means any stock or securities (other than Options) directly or indirectly convertible into or exercisable or exchangeable for Ordinary
        Shares.

      

      

      (e)          “Eligible Market” means the Principal Market, The New York Stock Exchange, Inc., The NYSE MKT, The NASDAQ Global Market or The NASDAQ Global Select Market.

      

      

      (f)          “Expiration Date” means the fifth (5th) anniversary of the Exercisability Date or, if such date falls on a day other than a Trading Day or on which trading does
        not take place on the Principal Market, or, if the Principal Market is not the principal trading market for the Ordinary Shares, then on the principal securities exchange or securities market on which the Ordinary Shares are then traded (a “Holiday”), the next date that is not a Holiday.

      

      

      (g)          “Fundamental Transaction” means that the Company shall, directly or indirectly, in one or more related transactions, (i) consolidate or merge with or into
        (whether or not the Company is the surviving corporation) another Person (but excluding a migratory merger effected solely for the purpose of changing the jurisdiction of incorporation of the Company), or (ii) sell, assign, transfer, convey or
        otherwise dispose of all or substantially all of the properties or assets of the Company to another Person, or (iii) allow another Person to make a purchase, tender or exchange offer that is accepted by the holders of more than 50% of the
        outstanding Ordinary Shares (not including any Ordinary Shares held by the Person or Persons making or party to, or associated or affiliated with the Persons making or party to, such purchase, tender or exchange offer), or (iv) consummate a stock
        purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme of arrangement) with another Person whereby such other Person acquires more than 50% of the outstanding Ordinary
        Shares (not including any Ordinary Shares held by the other Person or other Persons making or party to, or associated or affiliated with the other Persons making or party to, such stock purchase agreement or other business combination), (v)
        reorganize, recapitalize or reclassify its Ordinary Shares, or (vi) any “person” or “group” (as these terms are used for purposes of Sections 13(d) and 14(d) of the Exchange Act) is or shall become the “beneficial owner” (as defined in Rule 13d-3
        under the Exchange Act), directly or indirectly, of 50% or more of the aggregate ordinary voting power represented by issued and outstanding Ordinary Shares.

      
        14

        
          


      

      (h)          “Options” means any rights, warrants or options to subscribe for or purchase Ordinary Shares or Convertible Securities.

      

      

      (i)          “Ordinary Shares” means (i) the Company’s Ordinary Shares, no par value, and (ii) any share capital into which such Ordinary Shares shall have been changed or any
        share capital resulting from a reclassification of such Ordinary Shares.

      

      

      (j)          “Parent Entity” of a Person means an entity that, directly or indirectly, controls the applicable Person and whose common stock or equivalent equity security is
        quoted or listed on an Eligible Market, or, if there is more than one such Person or Parent Entity, the Person or Parent Entity with the largest public market capitalization as of the date of consummation of the Fundamental Transaction.

      

      

      (k)          “Person” means an individual, a limited liability company, a partnership, a joint venture, a corporation, a trust, an unincorporated organization, any other
        entity and a government or any department or agency thereof.

      

      

      (l)          “Principal Market” means The NASDAQ Capital Market.

      

      

      (m)          “Required Holders” means, as of any date, the holders of at least a majority of the Warrants outstanding as of such date.

      

      

      (n)          “Successor Entity” means the Person (or, if so elected by the Holder, the Parent Entity) formed by, resulting from or surviving any Fundamental Transaction or the
        Person (or, if so elected by the Holder, the Parent Entity) with which such Fundamental Transaction shall have been entered into.

      

      

      (o)          “Trading Day” means any day on which the Ordinary Shares are traded on the Principal Market, or, if the Principal Market is not the principal trading market for
        the Ordinary Shares, then on the principal securities exchange or securities market on which the Ordinary Shares are then traded; provided that “Trading Day” shall not include any day on which the Ordinary
        Shares are scheduled to trade on such exchange or market for less than 4.5 hours or any day that the Ordinary Shares are suspended from trading during the final hour of trading on such exchange or market (or if such exchange or market does not
        designate in advance the closing time of trading on such exchange or market, then during the hour ending at 4:00:00 p.m., New York time).

      

      

      (p)          “Weighted Average Price” means, for any security as of any date, the dollar volume-weighted average price for such security on the Principal Market during the
        period beginning at 9:30:01 a.m., New York time (or such other time as the Principal Market publicly announces is the official open of trading), and ending at 4:00:00 p.m., New York time (or such other time as the Principal Market publicly
        announces is the official close of trading), as reported by Bloomberg through its “Volume at Price” function or, if the foregoing does not apply, the dollar volume-weighted average price of such security in the over-the-counter market on the
        electronic bulletin board for such security during the period beginning at 9:30:01 a.m., New York time (or such other time as the Principal Market publicly announces is the official open of trading), and ending at 4:00:00 p.m., New York time (or
        such other time as the Principal Market publicly announces is the official close of trading), as reported by Bloomberg, or, if no dollar volume-weighted average price is reported for such security by Bloomberg for such hours, the average of the
        highest closing bid price and the lowest closing ask price of any of the market makers for such security as reported in the “pink sheets” by OTC Markets Group, Inc. If the Weighted Average Price cannot be calculated for a security on a particular
        date on any of the foregoing bases, the Weighted Average Price of such security on such date shall be the fair market value as mutually determined by the Company and the Holder. If the Company and the Holder are unable to agree upon the fair market
        value of such security, then such dispute shall be resolved pursuant to Section 13 with the term “Weighted Average Price” being substituted for the term “Exercise Price.” All such determinations shall be appropriately adjusted for any stock
        dividend, stock split, stock combination or other similar transaction during the applicable calculation period.

      

      

      [Signature Page Follows]

      
        15

        
          


      

      IN WITNESS WHEREOF, the Company has caused this Warrant to Purchase Ordinary Shares to be duly executed as of the Issuance Date set out above.

       

      

      	 	
              VERDANT EARTH TECHNOLOGIES LIMITED

            
	 	 
	 	
              By: 

            	

            
	 	
              Name:

            	 
	 	
              Title:

            	 


      

      

      
        
          


      

      
      EXHIBIT A

      

      

      EXERCISE NOTICE

      

      

      TO BE EXECUTED BY THE REGISTERED HOLDER TO EXERCISE THIS

      WARRANT TO PURCHASE ORDINARY SHARES

      

      

      VERDANT EARTH TECHNOLOGIES LIMITED

      

      

      The undersigned holder hereby exercises the right to purchase _________________ of the Ordinary Shares (“Warrant Shares”) of Verdant Earth Technologies Limited, a company
        limited by shares incorporated and domiciled in Australia (the “Company”), evidenced by the attached Warrant to Purchase Ordinary Shares (the “Warrant”). Capitalized
        terms used herein and not otherwise defined shall have the respective meanings set forth in the Warrant.

      

      

      1. Form of Exercise Price. The Holder intends that payment of the Exercise Price shall be made as:

      

      

      ____________a “Cash Exercise” with respect to _________________ Warrant Shares; and/or

      

      

      ____________a “Cashless Exercise” with respect to _______________ Warrant Shares.

      

      

      2. Payment of Exercise Price. In the event that the holder has elected a Cash Exercise with respect to some or all of the Warrant Shares to be issued pursuant hereto, the holder shall pay the Aggregate
        Exercise Price in the sum of $___________________ to the Company in accordance with the terms of the Warrant.

      

      

      3. Delivery of Warrant Shares. The Company shall deliver to the holder __________ Warrant Shares in accordance with the terms of the Warrant and, after delivery of such Warrant Shares, _____________ Warrant
        Shares remain subject to the Warrant.

      

      

      4. Representations and Warranties. By its delivery of this Exercise Notice, the undersigned represents and warrants to the Company that in giving effect to the exercise evidenced hereby the Holder will not
        beneficially own in excess of the number of Ordinary Shares (determined in accordance with Section 13(d) of the Securities Exchange Act of 1934, as amended) permitted to be owned under Section 1(g) of this Warrant to which this notice relates.

      

      

      Date: _______________ __, ______

      

      

       

      

      _____________________________

      

      Name of Registered Holder

      

      

      	
              By:

            	 	 	 
	 	
              Name:

            	 
	 	
              Title:

            	 


      

      

      
        A-1

        
          


      

      EXHIBIT B

      

      

      ASSIGNMENT FORM

      

      

      VERDANT EARTH TECHNOLOGIES LIMITED

      

      

      (To assign the foregoing Warrant, execute this form and supply required information. Do not use this form to purchase shares.)

      

      

      FOR VALUE RECEIVED, the foregoing Warrant and all rights evidenced thereby are hereby assigned to

      

      

       

      

      	 	 	 
	
              Name:

            	 	 
	 	 	
              (Please Print)

            
	 	 
	
              Address:

            	 	 
	 	 	
              (Please Print)

            
	 	 
	
              Dated: _______________ __, ______

            	 	 
	 	 
	
              Holder’s Signature:___________________________

            	 	 
	 	 
	
              Holder’s Address: ____________________________

            	 	 
	 	 	 


      NOTE: If the Holder is an individual, the signature to this Assignment Form must correspond with such Holder’s name as it appears on the face of the Warrant. Those acting in a fiduciary or other representative capacity should file proper
        evidence of authority to assign the foregoing Warrant.

      

      

      B-1